Literature DB >> 8389690

Sites of action of naloxone in precipitating withdrawal jumping in morphine-dependent mice: investigations by the ED50 value and CNS content of naloxone.

Y Miyamoto1, A E Takemori.   

Abstract

The sites of action of naloxone and the possible interaction between supraspinally and spinally administered naloxone in precipitating withdrawal jumping were investigated by comparing the ED50 value and central nervous system (CNS) content of naloxone after three different administration routes in morphine-dependent mice. ED50 values of naloxone for i.c.v., i.t. and s.c. routes were 18.8 nmol, 1.95 nmol and 50.6 nmol/kg, respectively. Jumping occurred most often within 5 min after i.t administered naloxone, but it took more than 10 min to reach the most frequent jumping after s.c. and i.c.v. administered naloxone. After equi-effective doses (ED50) of naloxone were administered i.c.v., i.t. or s.c., the content of naloxone in the brain was 70 times lower after s.c. than that after i.c.v. injection. The concentration of naloxone in the spinal cord was 37 times lower after s.c. than that after i.t. injection. The ED50 values of naloxone and the time courses of jumping suggest that spinal sites appear to be more important than the supraspinal sites and comparisons of naloxone-content suggest that there is a synergistic interaction between supraspinal- and spinal-naloxone after systemic administration.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389690     DOI: 10.1016/0376-8716(93)80009-4

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  2 in total

1.  Genetic correlates of morphine withdrawal in 14 inbred mouse strains.

Authors:  Pamela Metten; John C Crabbe; John K Belknap
Journal:  Drug Alcohol Depend       Date:  2008-09-06       Impact factor: 4.492

Review 2.  Endogenous opiates: 1993.

Authors:  G A Olson; R D Olson; A J Kastin
Journal:  Peptides       Date:  1994       Impact factor: 3.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.